The NAT2* slow acetylator genotype is associated with bladder cancer in Taiwanese, but not in the Black Foot Disease endemic area population

Pharmacogenetics. 1998 Apr;8(2):187-90. doi: 10.1097/00008571-199804000-00011.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylation
  • Arsenic / toxicity
  • Arylamine N-Acetyltransferase / genetics*
  • Carcinogens / toxicity
  • Case-Control Studies
  • Environmental Exposure
  • Genotype
  • Humans
  • Taiwan / ethnology
  • Urinary Bladder Neoplasms / ethnology
  • Urinary Bladder Neoplasms / genetics*

Substances

  • Carcinogens
  • Arylamine N-Acetyltransferase
  • NAT2 protein, human
  • Arsenic